Local Phone: 0845 260 2602
Acella Pharmaceuticals, in collaboration with its sister company Neuvosyn Laboratories, has announced encouraging topline results from a phase 2...
Read MoreXeltis has announced highly successful results from its aXess EU phase 3 clinical trial, marking a major milestone in...
Read MoreModus Therapeutics will present new research findings on its investigational drug sevuparin for chronic kidney disease (CKD) with anemia...
Read MoreThe European Commission has approved ROMVIMZA (vimseltinib) for the treatment of adult patients with symptomatic tenosynovial giant cell tumour...
Read MorePMV Pharmaceuticals has announced encouraging interim findings from the phase 2 portion of its PYNNACLE trial, which is evaluating...
Read MoreLundbeck has presented compelling new clinical data on its migraine therapy eptinezumab at the 2025 International Headache Congress (IHC)...
Read More
